[go: up one dir, main page]

MX2016012697A - Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. - Google Patents

Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.

Info

Publication number
MX2016012697A
MX2016012697A MX2016012697A MX2016012697A MX2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A
Authority
MX
Mexico
Prior art keywords
protein biomarker
colorectal tumors
biomarker profiles
detecting colorectal
disclosed
Prior art date
Application number
MX2016012697A
Other languages
English (en)
Inventor
John Blume
Ryan Benz
Lisa Croner
Roslyn Dillon
Jeffrey Jones
Heather Skor
Bruce Wilcox
Kao Athit
Preston Richard
Original Assignee
Applied Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Proteomics Inc filed Critical Applied Proteomics Inc
Publication of MX2016012697A publication Critical patent/MX2016012697A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen en la presente paneles relacionados con el diagnóstico o reconocimiento de cáncer de colon y colorrectal en un sujeto. Los paneles y métodos relacionados descritos son usados para predecir o evaluar el estado del cáncer de colon en un paciente. Ellos pueden ser usados para determinar la naturaleza del tumor, la recurrencia, o la respuesta del paciente a los tratamientos. Algunas modalidades de los métodos incluyen la generación de un reporte para el manejo clínico.
MX2016012697A 2014-03-28 2015-03-27 Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. MX2016012697A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461972153P 2014-03-28 2014-03-28
US201462005835P 2014-05-30 2014-05-30
US201562107265P 2015-01-23 2015-01-23
PCT/US2015/023187 WO2015149030A1 (en) 2014-03-28 2015-03-27 Protein biomarker profiles for detecting colorectal tumors

Publications (1)

Publication Number Publication Date
MX2016012697A true MX2016012697A (es) 2017-05-09

Family

ID=54196479

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012697A MX2016012697A (es) 2014-03-28 2015-03-27 Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.

Country Status (10)

Country Link
US (1) US20170176441A1 (es)
EP (1) EP3123171A4 (es)
JP (1) JP2017520775A (es)
CN (1) CN106461647A (es)
AU (1) AU2015237229A1 (es)
CA (1) CA2943827A1 (es)
IL (1) IL247987A0 (es)
MX (1) MX2016012697A (es)
SG (1) SG11201608053PA (es)
WO (1) WO2015149030A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
US20190113520A1 (en) * 2016-03-31 2019-04-18 Discerndx, Inc. Biomarker Database Generation and Use
CN106279403B (zh) * 2016-08-16 2019-06-11 长春市海兰深生物医学技术有限公司 一种检测天然肺癌相关抗体的组合物、试剂盒和方法
US20180100858A1 (en) * 2016-10-07 2018-04-12 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CN107505461B (zh) * 2017-08-31 2020-05-08 北京臻惠康生物科技有限公司 一种纤维蛋白原γ链的新用途及试剂盒
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND MONITORING OF TREATMENT
EP3697925A4 (en) * 2017-10-18 2021-06-23 Venn Biosciences Corporation IDENTIFICATION AND USE OF BIOLOGICAL PARAMETERS FOR THE DIAGNOSIS AND MONITORING OF A TREATMENT
CN109580948B (zh) * 2018-11-30 2021-08-10 中国科学院上海有机化学研究所 基于二氢胸腺嘧啶代谢物的组合在结直肠癌诊断及预后预测中的应用
CN111253492B (zh) * 2018-11-30 2021-10-08 华中科技大学 一种透脑性多肽及其在制备防治老年痴呆药物中应用
EP4065981A4 (en) * 2019-12-28 2023-05-24 Precogify Pharmaceutical China Co., Ltd. BIOMARKERS FOR THE DETECTION OF CANCER OR COLORECTAL ADENOMA AND RELATED METHODS
CN112501294B (zh) * 2020-12-03 2022-10-04 中山大学 一种结直肠癌生物标志物及其应用
CN112881692B (zh) * 2021-01-08 2022-11-22 深圳华大基因股份有限公司 一种用于结直肠癌及腺瘤早期筛查的蛋白定量检测方法
CN118588280A (zh) * 2024-05-21 2024-09-03 杭州度安医学检验实验室有限公司 一种基于蛋白标志物组合和临床特征判断肺部结节良恶性的系统、设备和介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004322162B2 (en) * 2004-08-13 2011-04-28 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma; method for detection and test system
WO2007016367A2 (en) * 2005-07-29 2007-02-08 Bayer Healthcare Llc Neoplastic disease-related methods, kits, systems and databases
NZ593226A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (efnb2) for colorectal cancer prognosis
JP2011517765A (ja) * 2007-06-04 2011-06-16 ダイアグノプレックス エセアー 結腸直腸癌のためのバイオマーカの組み合わせ
EP3444358A1 (en) * 2009-02-20 2019-02-20 Onconome, Inc. Methods for diagnosis and prognosis of colorectal cancer
EP2593795A4 (en) * 2010-07-14 2014-01-22 Commw Scient Ind Res Org DIAGNOSIS FOR DARM CANCER
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
KR20150090240A (ko) * 2012-11-30 2015-08-05 어플라이드 프로테오믹스, 인크. 결장 종양의 존재 또는 위험의 평가 방법

Also Published As

Publication number Publication date
CN106461647A (zh) 2017-02-22
EP3123171A4 (en) 2018-01-03
SG11201608053PA (en) 2016-10-28
CA2943827A1 (en) 2015-10-01
IL247987A0 (en) 2016-11-30
JP2017520775A (ja) 2017-07-27
WO2015149030A1 (en) 2015-10-01
EP3123171A1 (en) 2017-02-01
AU2015237229A1 (en) 2016-11-10
US20170176441A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
HK1248316B (zh) 评估个体结肠直肠健康的方法
CY1121723T1 (el) Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων
MX2015006757A (es) Método para la evaluación de la presencia de o riesgo de tumores de colon.
MY176706A (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
MX361058B (es) Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.
MX2023002251A (es) Antagonistas de union al eje pd-l1 y usos de los mismos para el tratamiento de cancer.
MX394474B (es) Métodos de pronóstico para cáncer de vejiga sin invasión muscular y antagonistas para usarse en el tratamiento de lo mismo.
MX2016012285A (es) Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
WO2014028884A3 (en) Cancer diagnostics using biomarkers
NZ732512A (en) Use of markers including filamin a in the diagnosis and treatment of prostate cancer
WO2016109782A3 (en) Methods and compositions for detecting colorectal neoplasias
MX2014005800A (es) Mutaciones del receptor notch humano y su uso.
MX368099B (es) Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
MX2018009254A (es) Metodos para evaluar el riesgo de desarrollar cancer colorrectal.
EA201691314A1 (ru) Терапевтические способы и композиции
EP3100046A4 (en) Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
MX392040B (es) Estandares de antigeno prostatico y sus usos.
EP4513187A3 (en) Methods of detecting prostate cancer
MA40636A (fr) Procédés pour détecter le cancer de la prostate
WO2015181555A8 (en) Expression profiling for determining the responsiveness of cancers to treatment with an anti-angiogenic agent
WO2016018524A8 (en) E2f4 signature for use in diagnosing and treating breast and bladder cancer
WO2015148645A3 (en) Methods and kits for the prognosis and treatment of prostate cancer